Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

Immune checkpoint inhibitors have shown anti-tumour activity in cancers such as melanoma, renal cell carcinoma, non-small-cell lung cancer, urothelial carcinoma, colorectal cancer, and Hodgkin’s lymphoma. Though immune checkpoint inhibitors have revolutionized the treatment and prognosis of some adv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Marta Rocha, João Correia de Sousa, Marta Salgado, António Araújo, Isabel Pedroto
Formato: Artigo
Idioma:Inglês
Publicado em: Karger Publishers 2018-12-01
Colecção:GE: Portuguese Journal of Gastroenterology
Assuntos:
Immune checkpoint inhibitor
Immune-related adverse event
Colitis
Diarrhoea
Acesso em linha:https://www.karger.com/Article/FullText/494569
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados